» Articles » PMID: 9458098

Analysis of PTEN/MMAC1 Alterations in Aerodigestive Tract Tumors

Overview
Journal Cancer Res
Specialty Oncology
Date 1998 Feb 11
PMID 9458098
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

PTEN/MMAC1 is a candidate tumor suppressor gene recently identified at chromosomal band 10q23. It is mutated in sporadic brain, breast, and prostate cancer and in the germ line of patients with hereditary Cowden disease. We searched for genetic alterations of the PTEN/MMAC1 gene in 39 primary head and neck cancers (HNSCCs), 42 primary non-small cell lung cancers (NSCLCs), 80 pancreatic cancer xenografts, and 37 cell lines and xenografts from colon, lung, and gastric cancers. Microsatellite analysis revealed loss of heterozygosity at markers near the gene in 41% of primary HNSCCs, 50% of NSCLCs, and 39% of the pancreatic cancers. Three cases of HNSCCs displayed homozygous deletion involving the gene. We sequenced the entire coding region of the PTEN/MMAC1 gene in the remaining tumors displaying loss of heterozygosity and found one terminating mutation in a HNSCC sample. Thus, a second inactivation event was observed in 4 of 39 primary HNSCC cases. By use of a protein truncation assay, one terminating mutation was also identified in one of eight NSCLC cell lines. Our results suggest that PTEN/MMAC1 gene inactivation plays a role in the genesis of some tumor types.

Citing Articles

Pancreatic Mixed Acinar-neuroendocrine Carcinoma in a Patient With a Germline Variant: A Case Report and Genomic Literature Review.

Saito Y, Suzuki S, Sanomachi T, Kato K, Otake H, Nishise Y In Vivo. 2025; 39(2):1173-1181.

PMID: 40010976 PMC: 11884457. DOI: 10.21873/invivo.13921.


WWP1 inhibition suppresses the proliferation of pancreatic cancer cells by regulating the PI3K-AKT pathway.

Notoya G, Kishikawa T, Yasugi K, Iwata T, Seimiya T, Miyabayashi K J Gastroenterol. 2024; 60(3):370-384.

PMID: 39656237 PMC: 11880106. DOI: 10.1007/s00535-024-02192-x.


Low-dose orthotopic cancer implantation permits measurement of longitudinal functional changes associated with cachexia.

Roy I, Binder-Markey B, Willbanks A, Sychowski D, Phipps T, Barber A J Appl Physiol (1985). 2024; 137(3):705-717.

PMID: 39052773 PMC: 11424168. DOI: 10.1152/japplphysiol.00173.2024.


Co-Targeting the EGFR and PI3K/Akt Pathway to Overcome Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma: What about Autophagy?.

Zaryouh H, Van Loenhout J, Peeters M, Vermorken J, Lardon F, Wouters A Cancers (Basel). 2022; 14(24).

PMID: 36551613 PMC: 9776372. DOI: 10.3390/cancers14246128.


Aurora Kinases as Therapeutic Targets in Head and Neck Cancer.

Nguyen T, Silva F, Golemis E Cancer J. 2022; 28(5):387-400.

PMID: 36165728 PMC: 9836054. DOI: 10.1097/PPO.0000000000000614.